DOCHERTY JOHN MARTIN 4
4 · Lexaria Bioscience Corp. · Filed Jun 9, 2021
Insider Transaction Report
Form 4
DOCHERTY JOHN MARTIN
DirectorPresident
Transactions
- Other
Stock Options
2021-05-07−18,334→ 31,334 totalExercise: $14.10From: 2020-02-07Exp: 2025-02-07→ Common Shares (18,334 underlying)
Holdings
- 54,075(indirect: Private Holding Company)
common shares
- 31,668
Stock Options
Exercise: $9.60From: 2020-04-23Exp: 2025-04-23→ Common Shares (13,334 underlying) - 18,334
Stock Options
Exercise: $14.10From: 2020-02-07Exp: 2025-02-07→ Common Shares (18,334 underlying) - 49,668
Stock Options
Exercise: $5.31From: 2021-04-26Exp: 2026-04-26→ Common Shares (18,000 underlying)
Footnotes (1)
- [F1]Cancellation of Options